CD69 and COVID-19: CD69 and PD1 expressing Vδ2+ T cells showed a higher level in severe patients compared to HDs, while CD69 expressing Vδ1 T cells but not PD1+ Vδ1 showed no significant change in severe patients compared with non-COVID-19 critically ill controls.